A research team led by Young Il Park at the Korea Research Institute of Chemical Technology is collaborating with Sung-Jin Park, with FDA approval being relevant for the US market.
1 report, 1 independent
Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A research team led by Young Il Park at the Korea Research Institute of Chemical Technology is collaborating with Sung-Jin Park, with FDA approval being relevant for the US market.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- Korea Research Institute of Chemical Technology
-
FDA
- Medicare eligibility rules affect AbbVie drug pricing, while the FDA regulates Creon's classification and approval for Medicare beneficiaries.
- Hemogenyx Pharmaceuticals Plc submitted an IND application for its HG-CT-1 therapy with the FDA and is building infrastructure for early commercialization in Europe.